Correlation between serum uric acid levels and residual platelet reactivity in patients undergoing PCI

Nutr Metab Cardiovasc Dis. 2017 May;27(5):470-471. doi: 10.1016/j.numecd.2017.02.006. Epub 2017 Mar 4.

Authors

G Ciccarelli¹, F Mangiacapra², M Pellicano³, E Barbato⁴

Affiliations

¹ Cardiovascular Research Center Aalst, OLV Hospital, Belgium; Department of Cardio-Thoracic Science, University of Campania "Luigi Vanvitelli", Naples, Italy.
² Unit of Cardiovascular Science, Department of Medicine Campus, Bio-Medico University of Rome, Italy.
³ Cardiovascular Research Center Aalst, OLV Hospital, Belgium; Department of Advance Biomedical Sciences, University of Naples Federico II, Italy.
⁴ Cardiovascular Research Center Aalst, OLV Hospital, Belgium; Department of Advance Biomedical Sciences, University of Naples Federico II, Italy. Electronic address: Emanuele.barbato@olvz-aalst.be.

PMID: 28428028
DOI: 10.1016/j.numecd.2017.02.006

No abstract available

Publication types

Letter

MeSH terms

Aged
Biomarkers / blood
Blood Platelets / drug effects*
Blood Platelets / metabolism
Coronary Artery Disease / blood
Coronary Artery Disease / diagnosis
Coronary Artery Disease / surgery*
Female
Humans
Hyperuricemia / blood*
Hyperuricemia / diagnosis
Male
Middle Aged
Percutaneous Coronary Intervention* / adverse effects
Platelet Aggregation Inhibitors / adverse effects
Platelet Aggregation Inhibitors / therapeutic use*
Platelet Function Tests
Purinergic P2Y Receptor Antagonists / adverse effects
Purinergic P2Y Receptor Antagonists / therapeutic use*
Receptors, Purinergic P2Y12 / blood
Receptors, Purinergic P2Y12 / drug effects
Risk Factors
Time Factors
Treatment Outcome
Uric Acid / blood*

Substances

Biomarkers
P2RY12 protein, human
Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Receptors, Purinergic P2Y12
Uric Acid